- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Patent holdings for IPC class A61K 47/20
Total number of patents in this class: 2366
10-year publication summary
|
153
|
188
|
197
|
202
|
268
|
243
|
241
|
272
|
222
|
27
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 108 |
42 |
| Eagle Pharmaceuticals, Inc. | 105 |
36 |
| Chugai Seiyaku Kabushiki Kaisha | 1387 |
31 |
| Arcturus Therapeutics, Inc. | 173 |
23 |
| Hisamitsu Pharmaceutical Co., Inc. | 784 |
22 |
| Heron Therapeutics, Inc. | 155 |
18 |
| Hanmi Pharm. Co., Ltd. | 587 |
17 |
| Arcutis Biotherapeutics, Inc. | 114 |
17 |
| NanoVation Therapeutics Inc. | 75 |
16 |
| Genentech, Inc. | 4040 |
15 |
| The Board of Regents of the University of Texas System | 2244 |
15 |
| Eagle Biologics, Inc. | 19 |
15 |
| Hoffmann-La Roche Inc. | 3602 |
14 |
| FUJIFILM Corporation | 30010 |
14 |
| Comera Life Sciences, Inc. | 26 |
14 |
| Janssen Biotech, Inc. | 1612 |
13 |
| Fennec Pharmaceuticals Inc. | 26 |
13 |
| Oculis Operations Sàrl | 38 |
13 |
| Cmpd Licensing, LLC | 81 |
12 |
| Merck Sharp & Dohme LLC | 3751 |
12 |
| Other owners | 1994 |